About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.07 (-30.00%)
AGN ASX Argenica Therapeutics Ltd
Argenica Therapeutics Ltd share price
Atividade de preço de AGN
Último preço
$ 0,070
Variação (24h)
-0,03 AUD (30,00%)
Volume
575.12K
Volume (média 4 sem.)
-
Abertura
$ 0,08
Variação do dia
$ 0,07 - $ 0,08
Fechamento anterior
$ 0,10
Último negócio
20 Nov, 3:05 am GMT+0
Atrasado
20 Nov, 3:05 am GMT+0
AGN price performance
Atrasado
20 Nov, 3:05 am GMT+0
AGN details
quote.marketSignals